Safety board recommends Canavaxin trial for stage III melanoma be discontinued
In: Health & Medicine Week, 2005-10-31, S. 423
Zeitungsartikel
Zugriff:
Titel: |
Safety board recommends Canavaxin trial for stage III melanoma be discontinued
|
---|---|
Zeitschrift: | Health & Medicine Week, 2005-10-31, S. 423 |
Veröffentlichung: | 2005 |
Medientyp: | Zeitungsartikel |
ISSN: | 1531-6459 (print) |
Sonstiges: |
|